Natco Pharma Ltd - ESG Rating & Company Profile powered by AI
The assessment of Natco Pharma Ltd leverages information from across the internet as well as from public documents by Natco Pharma Ltd. Alternative companies in the rating industry group for Natco Pharma Ltd are shown below. If you are employed by Natco Pharma Ltd and you would like to licence your ESG aseessment, please contact us.
Natco Pharma Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.6; made up of an environmental score of 8.0, social score of 8.0 and governance score of 6.7.
7.6
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 140 | Sun Pharmaceutical Industries Ltd | 7.7 | High |
| 140 | Teva Pharmaceutical Industries Ltd | 7.7 | High |
| 149 | Natco Pharma Ltd | 7.6 | High |
| 149 | Alexion Pharmaceuticals Inc | 7.6 | High |
| 149 | Hisamitsu Pharmaceutical Co Inc | 7.6 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Natco Pharma Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Natco Pharma Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Natco Pharma Ltd report the average age of the workforce?
Sign up for free to unlockDoes Natco Pharma Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Natco Pharma Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Natco Pharma Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Natco Pharma Ltd offer flexible work?
Sign up for free to unlockDoes Natco Pharma Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Natco Pharma Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Natco Pharma Ltd conduct supply chain audits?
Sign up for free to unlockDoes Natco Pharma Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Natco Pharma Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Natco Pharma Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Natco Pharma Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Natco Pharma Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Natco Pharma Ltd disclose water use targets?
Sign up for free to unlockDoes Natco Pharma Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Natco Pharma Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Natco Pharma Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Natco Pharma Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Natco Pharma Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Natco Pharma Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Natco Pharma Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Natco Pharma Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Natco Pharma Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Natco Pharma Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Natco Pharma Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Natco Pharma Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Natco Pharma Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Natco Pharma Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Natco Pharma Ltd disclose its waste policy?
Sign up for free to unlockDoes Natco Pharma Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Natco Pharma Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Natco Pharma Ltd disclose energy use targets?
Sign up for free to unlockDoes Natco Pharma Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Natco Pharma Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Natco Pharma Ltd
These potential risks are based on the size, segment and geographies of the company.
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF; and agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. The company markets its products in approximately 50 countries. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.